JG

JAMES GREENWOOD

DLA PIPER LLP (US) · Washington, DC · registered since 2024
Registered · LDAActive

At a glance

Registered since
2024
Senate LDA system
Clients
4
last 3 years
Filings
5
2 agencies contacted
Activity
filings by quarter
Works on

Background

Career
Washington, DC
2024 - present

Specific issues

Government contracting issues. Reauthorization of the Pandemic and All Hazards Preparedness Act. Data privacy proposals. H.R. 9029, Labor/HHS/Education Appropriations, FY2025, support for data-driven products and services.
Health Issues · 2024 Q2
Issues related to drug pricing, Medicare reimbursement, implementation of the Inflation Reduction Act, and mental health.
Health Issues · 2024 Q1
Government contracting issues. H.R. 5894/S. 2624, Labor/HHS/Education Appropriations Act, FY2024, support for data-driven products and services. Reauthorization of the Pandemic and All Hazards Preparedness Act. Data privacy proposals. Labor/HHS/Education Appropriations, FY2025, support for data-driven products and services.
Health Issues · 2024 Q1
Policies related to drug approval for treatment of rare diseases. Policies related to exclusivity of small molecule drugs. H.R. 4408/S. 1906, Promising Pathway Act.
Health Issues · 2024 Q1
Legislative and regulatory policies and proposals related to obesity treatment, including H.R. 4818/S. 2408, the Treat and Reduce Obesity Act of 2023.
Pharmacy · 2024 Q1

Clients

2024 · 2 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock
$██,███ / qtrUnlock
$██,███ / qtrUnlock

Filing history

2024 Q2
IQVIA HOLDINGS, INC.
Q2lda.gov →
2024 Q1
INTRA-CELLULAR THERAPIES, INC.
Q1lda.gov →
2024 Q1
IQVIA HOLDINGS, INC.
Q1lda.gov →
2024 Q1
CURRAX PHARMACEUTICALS LLC
Q1lda.gov →
2024 Q1
BIOHAVEN PHARMACEUTICALS, INC.
Q1lda.gov →
Showing recent filings · full history on lda.gov